
Summary for Tradename: XYZAL
|
|
Latest news for XYZALReportlinker Adds Allergic Rhinitis - Pipeline Assessment and Market Forecasts to 201719 July 2010, 10:57 am Fera Pharmaceuticals launches Neptazanetm tablets for reducing intraocular pressure3 July 2010, 4:07 am Courtesy of Yahoo News |
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | XYZAL | levocetirizine dihydrochloride | 022064 | May 25, 2007 | RX | Yes | Aug 21, 2012 | |||||
| Ucb Inc | XYZAL | levocetirizine dihydrochloride | 022064 | May 25, 2007 | RX | Yes | Feb 21, 2013 | |||||
| Ucb Inc | XYZAL | levocetirizine dihydrochloride | 022064 | May 25, 2007 | RX | Yes | May 25, 2010 |
| Drugname | Dosage | Strength | RLD | Submissiondate |
| levocetirizine dihydrochloride | Oral Solution | 0.5 mg/mL | Xyzal | 1/14/2009 |
| levocetirizine dihydrochloride | Tablets | 5 mg | Xyzal | 12/17/2007 |
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.